Sitryx
Founded 2018 · 49 employees on LinkedIn · 4 known investors
Find your way into Sitryx
Sitryx is a biotechnology company, founded in 2018, developing therapeutics with a focus on immunometabolism. It has entered a global licensing and research collaboration with Eli Lilly and Company.
Investors · 4
Frequently asked questions
- What does Sitryx do?
- Sitryx is a biotechnology company, founded in 2018, developing therapeutics with a focus on immunometabolism. It has entered a global licensing and research collaboration with Eli Lilly and Company.
- Who are Sitryx's investors?
- Sitryx's investors include Longwood Fund, Oxford Science Enterprises, Sofinnova Partners, SV Health Investors.



